The IHC-based assessment of AKR1B10 in patients with chronic HCV and HBV infection showed that high AKR1B10 expression was an independent risk factor for HCC (HRs: 6.43 and 10.8, p < 0.001, respectively). The gene discussed is AKR1B10; the disease is hepatocellular carcinoma.